Cargando…
A non-endoscopic device to sample the oesophageal microbiota: a case-control study
BACKGROUND: The strongest risk factor for oesophageal adenocarcinoma is reflux disease, and the rising incidence of this coincides with the eradication of Helicobacter pylori, both of which might alter the oesophageal microbiota. We aimed to profile the microbiota at different stages of Barrett'...
Autores principales: | Elliott, Daffolyn R Fels, Walker, Alan W, O'Donovan, Maria, Parkhill, Julian, Fitzgerald, Rebecca C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656094/ https://www.ncbi.nlm.nih.gov/pubmed/28404012 http://dx.doi.org/10.1016/S2468-1253(16)30086-3 |
Ejemplares similares
-
Application of a multi‐gene next‐generation sequencing panel to a non‐invasive oesophageal cell‐sampling device to diagnose dysplastic Barrett's oesophagus
por: Katz‐Summercorn, Annalise, et al.
Publicado: (2017) -
Impact of mutations in Toll-like receptor pathway genes on esophageal carcinogenesis
por: Fels Elliott, Daffolyn Rachael, et al.
Publicado: (2017) -
Quantification of TFF3 expression from a non-endoscopic device predicts clinically relevant Barrett's oesophagus by machine learning
por: Berman, Adam G., et al.
Publicado: (2022) -
Use of a non-endoscopic immunocytological device (Cytosponge™) for post chemoradiotherapy surveillance in patients with oesophageal cancer in the UK (CYTOFLOC): A multicentre feasibility study
por: Jones, Christopher M., et al.
Publicado: (2022) -
Alterations in the Ca(2+) toolkit in oesophageal adenocarcinoma
por: Cutliffe, Alana L., et al.
Publicado: (2021)